Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases.

Nitric oxide synthesized from l-arginine by nitric oxide synthase isoforms (NOS-I-III) is physiologically important but also can be deleterious when overproduced. Selective NOS inhibitors are of clinical interest, given their differing pathophysiological roles. Here we describe our approach to target the unique NOS (6R,1'R,2'S)-5,6,7,8-tetrahydrobiopterin (H(4)Bip) binding site. By a combination of ligand- and structure-based design, the structure-activity relationship (SAR) for a focused set of 41 pteridine analogues on four scaffolds was developed, revealing selective NOS-I inhibitors. The X-ray crystal structure of rat NOS-I dimeric-oxygenase domain with H(4)Bip and l-arginine was determined and used for human isoform homology modeling. All available NOS structural information was subjected to comparative analysis of favorable protein-ligand interactions using the GRID/concensus principal component analysis (CPCA) approach to identify the isoform-specific interaction site. Our interpretation, based on protein structures, is in good agreement with the ligand SAR and thus permits the rational design of next-generation inhibitors targeting the H(4)Bip binding site with enhanced isoform selectivity for therapeutics in pathology with NO overproduction.

[1]  R. Weinberg,et al.  Pterin interactions with distinct reductase activities of NO synthase. , 2001, The Biochemical journal.

[2]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[3]  E. Werner,et al.  Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. , 1997, Biochemistry.

[4]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[5]  H. Matter,et al.  Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. , 2002, Journal of medicinal chemistry.

[6]  P. Martásek,et al.  Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors. , 2004, Journal of medicinal chemistry.

[7]  Wolfgang Heiden,et al.  Fast generation of molecular surfaces from 3D data fields with an enhanced “marching cube” algorithm , 1993, J. Comput. Chem..

[8]  H. Schmidt,et al.  Tetrahydrobiopterin Inhibits Monomerization and Is Consumed during Catalysis in Neuronal NO Synthase* , 1999, The Journal of Biological Chemistry.

[9]  H. Schmidt,et al.  Allosteric regulation of neuronal nitric oxide synthase by tetrahydrobiopterin and suppression of auto-damaging superoxide. , 2000, The Biochemical journal.

[10]  J. Tainer,et al.  The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. , 1997, Science.

[11]  R. Wade,et al.  New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure. , 1989, Journal of medicinal chemistry.

[12]  I. Schlichting,et al.  Structural Basis for the Specificity of the Nitric-oxide Synthase Inhibitors W1400 and Nω-Propyl-l-Arg for the Inducible and Neuronal Isoforms* , 2003, Journal of Biological Chemistry.

[13]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[14]  H. Esumi,et al.  Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells. , 1995, Biochemical and biophysical research communications.

[15]  T. Poulos,et al.  Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase , 2004, Nature Structural &Molecular Biology.

[16]  J. Macgregor,et al.  Analysis of multiblock and hierarchical PCA and PLS models , 1998 .

[17]  Mika A. Kastenholz,et al.  GRID/CPCA: a new computational tool to design selective ligands. , 2000, Journal of medicinal chemistry.

[18]  R. Wade,et al.  Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. , 1993, Journal of medicinal chemistry.

[19]  John P. Overington,et al.  Knowledge‐based protein modelling and design , 1988 .

[20]  T. Poulos,et al.  Implications for Isoform-selective Inhibitor Design Derived from the Binding Mode of Bulky Isothioureas to the Heme Domain of Endothelial Nitric-oxide Synthase* , 2001, The Journal of Biological Chemistry.

[21]  H. Matter,et al.  Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor. , 1999, Journal of medicinal chemistry.

[22]  R C Wade,et al.  Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. , 1993, Journal of medicinal chemistry.

[23]  E. Werner,et al.  The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[25]  Gabriele Cruciani,et al.  Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID/CPCA approach. , 2002, Journal of medicinal chemistry.

[26]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[27]  G. Milne,et al.  Structure-based identification of a ricin inhibitor. , 1997, Journal of molecular biology.

[28]  P. Martásek,et al.  Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase. , 2001, Journal of medicinal chemistry.

[29]  J. Tainer,et al.  Structures of the N(omega)-hydroxy-L-arginine complex of inducible nitric oxide synthase oxygenase dimer with active and inactive pterins. , 2000, Biochemistry.

[30]  T. Andersson,et al.  Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA. , 2001, Journal of medicinal chemistry.

[31]  O. Griffith,et al.  Design of isoform-selective inhibitors of nitric oxide synthase. , 1998, Current opinion in chemical biology.

[32]  M. L. Connolly.  Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.

[33]  M. L. Connolly.  Analytical molecular surface calculation , 1983 .

[34]  T L Blundell,et al.  Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. , 1987, Protein engineering.

[35]  T. Poulos,et al.  The novel binding mode of N-alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. , 2002, Biochemistry.

[36]  T. Poulos,et al.  Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors. , 2003, Journal of medicinal chemistry.

[37]  E. Werner,et al.  Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. , 1996, The Biochemical journal.

[38]  P. Martásek,et al.  Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. , 2003, Journal of medicinal chemistry.

[39]  G. Prestwich,et al.  Anti-pterins as Tools to Characterize the Function of Tetrahydrobiopterin in NO Synthase* , 1998, The Journal of Biological Chemistry.

[40]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[41]  Brian Crane,et al.  Characterization of key residues in the subdomain encoded by exons 8 and 9 of human inducible nitric oxide synthase: A critical role for Asp-280 in substrate binding and subunit interactions , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Colin McMartin,et al.  QXP: Powerful, rapid computer algorithms for structure-based drug design , 1997, J. Comput. Aided Mol. Des..

[43]  H. Matter,et al.  Structural Basis for Pterin Antagonism in Nitric-oxide Synthase , 2001, The Journal of Biological Chemistry.

[44]  John P. Overington,et al.  18th Sir Hans Krebs lecture. Knowledge-based protein modelling and design. , 1988, European journal of biochemistry.

[45]  E. Werner,et al.  Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue. , 2000, Shock.

[46]  R. Stroud,et al.  Entropy in bi-substrate enzymes: proposed role of an alternate site in chaperoning substrate into, and products out of, thymidylate synthase. , 1996, Journal of molecular biology.

[47]  Hans Matter,et al.  Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors. , 2002, Journal of medicinal chemistry.

[48]  H. Schmidt,et al.  Renal toxicity of the neuron-blocking and mitochondriotropic agent m-iodobenzylguanidine , 1998, Cancer Chemotherapy and Pharmacology.

[49]  T. Poulos,et al.  Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase A Paradigm for Pterin Function Involving a Novel Metal Center , 1998, Cell.

[50]  T. Blundell,et al.  Knowledge based modelling of homologous proteins, Part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures. , 1987, Protein engineering.

[51]  J. Tainer,et al.  Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. , 1998, Science.

[52]  P. Weber,et al.  Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation , 1999, Nature Structural Biology.